Immuneel Therapeutics Pvt Ltd is a pioneering startup company leading the charge in cell therapy and personalized immunotherapy for patients.

Basic Information

Founded in 2019 by Kiran Mazumdar-Shaw, Founder and Chairperson of Biocon; US-based oncologist and author Dr Siddhartha Mukherjee; and Dr Kush Parmar, Founder of Boston-based 5AM Ventures; Immuneel Therapeutics offers cell and gene therapy to treat cancer at affordable prices in India. The company also announced that it has initiated patient dosing as part of phase II trials of its Chimeric Antigen Receptor T-cell therapy (CAR-T) to target blood cancer under the name IMAGINE at Narayana Hrudyalaya in Bengaluru. The trial is funded by Immuneel and will include 24 pediatric and adult cancer patients. The startup has exclusive rights to manufacture and commercialise the CAR-T cell therapy—currently under trial in India—from Hospital Clínic de Barcelona and Institut d’Investigacions Biomèdiques August Pi i Sunyer in Spain. See more

Legal Name

:

Immuneel Therapeutics Pvt Ltd

Headquarters

:

Bengaluru, Karnataka, India

Founding Date

:

2018

No. of Employees

:

41 to 60

Core Team

:
1.

Kiran Mazumdar-Shaw

Co-Founder

2.

Siddhartha Mukherjee

Co-Founder

3.

Kush Parmar

Co-Founder

Funding

Total Funding

$15.0M

Investors

:

1.

True North

2.

Eight Roads Ventures

3.

F-Prime Capital